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Abstract	
Objectives:	Employment	following	illness	is	associated	with	better	physical	and	psychological	
functioning.	This	study	aimed	to	assess	the	feasibility	and	acceptability	of	a	theoretically-led	
workbook	intervention	designed	to	support	cancer	patients	returning	to	work.	
Design:	Parallel-group	randomized	controlled	trial	with	embedded	qualitative	interviews	
Setting:	Oncology	clinics	within	four	English	National	Health	Service	Trusts	
Participants:	Patients	who	had	received	a	diagnosis	of	breast,	gynecological,	prostate	or	colorectal	
cancer	and	who	were	at	least	2	weeks	post-treatment	initiation.		
Intervention:	A	self-guided	WorkPlan	workbook	designed	to	support	cancer	patients	to	return	to	
work	with	fortnightly	telephone	support	calls	to	discuss	progress.	The	control	group	received	
treatment	as	usual,	and	were	offered	the	workbook	at	the	end	of	their	12-month	follow-up.	
Outcome	measures:		We	assessed	aspects	of	feasibility	including	eligibility,	recruitment,	data	
collection,	attrition,	feasibility	of	the	methodology,	acceptability	of	the	intervention	and	potential	to	
calculate	cost-effectiveness.		
Results:	The	recruitment	rate	of	eligible	patients	was	44%;	68	participants	consented	and	58	(85%)	
completed	baseline	measures.	Randomization	procedures	were	acceptable,	data	collection	methods	
(including	cost-effectiveness	data)	were	feasible	and	the	intervention	was	acceptable	to	participants.	
Retention	rates	at	six	and	12	months	follow-up	were	72%	and	69%	respectively.	At	6-month	follow-
up	30%	of	the	usual	care	group	had	returned	to	full	or	part-time	work	(including	phased	return	to	
work)	compared	to	43%	of	the	intervention	group.	At	12-months	the	percentages	were	47%	(usual	
care)	and	68%	(intervention).	
Conclusions:	The	findings	confirm	the	feasibility	of	a	definitive	trial,	although	further	consideration	
needs	to	be	given	to	increasing	the	participation	rates	among	men	and	Black	and	ethnic	minority	
patients	diagnosed	with	cancer.	
Trial	registration:	International	Standard	Randomized	Controlled	Trial	Number	(ISRCTN):	
ISRCTN56342476	
Strengths	and	limitations	of	this	study	
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• The	study	assessed	the	feasibility	and	acceptability	of	a	randomized	controlled	trial	(RCT)	of	a	
theory-led	intervention	to	support	return	to	work	among	patients	with	a	diagnosis	of	breast,	
gynecological,	colorectal	or	prostate	cancer.	
• The	intervention	used	a	workbook	format	comprising	of	paper-based	exercises	and	the	
development	of	a	return	to	work	plan.	
• A	mixed	method	design,	with	nested	qualitative	interviews,	was	used	to	assess	the	acceptability	
of	the	intervention,	the	feasibility	of	the	RCT	and	to	determine	the	utility	of	the	patient	reported	
outcome	measures	(PROMS).		
• Only	four	cancer	types	were	included,	which	may	limit	generalizability.	
• Views	of	male	participants,	as	well	as	Black	and	ethnic	minority	participants,	were	under	
represented,	as	the	majority	of	participants	were	female	and	Caucasian	and	all	were	English	
speaking.		
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Introduction		
Almost	half	of	adult	cancer	survivors	are	of	working	age1,	yet	cancer	patients	are	1.4	times	more	
likely	to	be	unemployed	than	healthy	individuals2.	Cancer	patients	may	experience	ongoing	negative	
outcomes	from	the	disease	or	treatment	(including	pain,	fatigue,	and	low	mood)	that	can	impact	
everyday	functioning,	including	work3,	4.	Return	to	work	rates	vary	across	cancer	types5,	however,	
longer	return	to	work	times	are	associated	with	certain	treatments	(e.g.	chemotherapy6),	fatigue7,	or	
a	non-	supportive	work	environment8.	Predictors	of	return	to	work	include	optimal	symptom	
management	(as	over	a	quarter	of	cancer	survivors	report	high	symptom	burden	one-year	post-
diagnosis,	even	after	the	end	of	treatment9),	implementing	appropriate	workplace	adaptations,	as	
well	as	specific	cancer	(i.e.	beliefs	about	the	consequences	of	cancer)	and	treatment-related	
perceptions	(i.e.	beliefs	about	controlling	the	effects	of	cancer	at	work).		
Employment	is	important	not	only	for	individual	financial	and	societal	economic	reasons	10	but	
because	being	out	of	work	is	thought	to	contribute	to,	and	aggravate,	adverse	health	outcomes	1,	11.	
Returning	to	and	staying	in	work	following	illness	is	associated	with	better	physical	and	psychological	
functioning.	Not	working	is	associated	with	reduced	self-esteem,	lowered	self-efficacy,	and	
decreased	belief	in	one's	ability	to	return	to	the	workplace	12.	Furthermore,	work	is	an	important	
component	of	quality	of	life	13	and	impaired	work	is	associated	with	increased	depression	and	
anxiety	among	cancer	patients	14.		
Several	interventions	to	support	working	have	been	developed	across	illness	groups,	including	
musculoskeletal	disorders,	back	pain	and	multiple	sclerosis.	These	interventions	have	tended	to	
focus	on	ergonomic	adaptation	within	the	workplace	with	the	aim	of	minimising	the	risk	of	physical	
injuries,	likely	to	be	experienced	by	these	patient	groups.	Interventions	targeted	at	cancer	patients	
include	a	12-week	occupational	physician-led	intervention	focused	on	increasing	physical	activity	to	
support	return	to	work	15;	a	case	management	approach	involving	signposting/referring	patients	to	
services	(e.g.	physiotherapy,	occupational	or	psychological	therapy)	to	support	return	to	work	16;	and	
a	tool	that	cancer	survivors	use	to	guide	discussions	about	working	17.	However,	this	tool	focused	on	
interactions	with	employers	and	healthcare	professionals	and	not	on	patients’	beliefs	and	barriers	
that	impact	workability	(one’s	perception	of	one’s	ability	to	work)	and	influence	work	behaviour.	
Furthermore,	a	Cochrane	review	reported	low	quality	evidence	for	return	to	work	rates	for	psycho-
educational	interventions	(interventions	that	encompass	a	broad	range	of	activities	that	combine	
educational	and	other	activities	such	as	counselling	and	supportive	care),	however	this	was	based	on	
only	two	studies;	one	which	focused	on	teaching	self-care	behaviours	to	manage	fatigue	and	one	
comprising	lectures	focused	on	side-effects,	stress	and	coping.	The	review	concluded	that	there	was	
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a	need	for	more	high-quality	randomized	controlled	trials	(RCTs)	18.	Furthermore,	a	meta-synthesis	
of	qualitative	research	studies	highlighted	the	need	for	vocational	interventions	with	cancer	patients	
to	be	person-centred	and	for	such	interventions	to	acknowledge	the	role	of	social,	clinical,	and	work-
related	factors	19.	
The	WorkPlan	intervention	is	theoretically	led	and	utilises	the	self-regulation	model	20	and	goal	
setting	theory	21.	WorkPlan	was	developed	following	the	MRC	guidelines	for	the	development	of	
complex	interventions	22	and	utilised	an	intervention	mapping	methodology	for	designing	and	
implementing	complex	interventions	or	programs.	WorkPlan	differs	from	other	published	
interventions	in	that	it	supports	people	diagnosed	with	cancer	to	prepare	for	returning	to	work	by	
creating	a	space	to	envisage	and	construct	a	future	at	work,	then	supporting	patients	to	develop	
appropriate	communication	and	planning	skills	to	support	returning	to	work.	The	workbook	
comprises	activities	aimed	at	eliciting	beliefs	about	the	impact	of	cancer	and	of	the	person’s	
perceived	workability,	identifying	actions	to	facilitate	the	process	of	returning	to	work	and	to	
support	specific	tasks	once	within	the	workplace.	The	individual	then	outlines	concrete	steps	to	
achieve	their	goals	through	a	structured	return	to	work	plan.	
Aims	
The	primary	objective	of	the	study	was	to	trial	the	WorkPlan	intervention	and	data	collection	
materials	to	determine	if	the	materials	were	acceptable	to	participants	and	whether	participants	
were	able	to	provide	full	answers.	The	aims	were	to:	
(1)	identify	whether	the	materials	and	intervention	were	acceptable	and	understandable		
(2)	determine	whether	the	recruitment	target	was	achievable	and	identify	the	most	successful	
methods	of	recruitment		
(3)	determine	the	acceptability	of	the	randomization	process		
(4)	identify	retention	rates	in	both	arms	
(5)	determine	if	data	were	obtainable	to	enable	a	full	cost-effectiveness	analysis	in	a	definitive	trial	
	
Methods	
A	full	description	of	the	protocol	is	available	elsewhere	23.		
Participants	
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The	target	was	to	recruit	60	participants	(30	randomized	into	each	group).	This	was	not	a	hypothesis	
testing	trial	and	the	sample	size	was	based	on	pragmatic	assumptions	around	feasible	recruitment	
figures	and	the	number	of	participants	required	to	estimate	the	key	parameters	around	the	
feasibility	of	a	full	RCT.	
Inclusion	criteria:	(a)	received	a	diagnosis	breast,	gynaecological,	prostate	or	colorectal	cancer;	(b)	
had	not	been	classified	as	having	metastatic	disease	or	recurrence;	(c)	at	least	2	weeks	post-
treatment	initiation;	(d)	aged	18	to	70	years;	(e)	working	at	the	time	of	diagnosis;	(f)	and	not	working	
at	time	of	recruitment	but	intended	to	return	to	work.	
Recruitment	and	randomisation	
Participants	were	recruited	by	researchers	and	research	nurses	through	four	English	National	Health	
Service	Trusts	UK.	Participants	were	identified	through	cancer	clinics,	multidisciplinary	team	
meetings,	and	by	placing	posters	and	leaflets	in	clinics,	support	and	information	services,	
chemotherapy	suites,	and	computerized	tomography	scan	waiting	areas.	All	recruitment	sites	were	
based	in	tertiary	care	centres.	In	addition,	collaborating	clinicians	were	provided	with	leaflets	and	
information	packs	outlining	the	study.	We	translated	recruitment	materials	into	the	five	most	
commonly	spoken	languages	among	people	of	working	age	in	Birmingham	(2011	Census):	Bengali,	
Chinese	(standard),	Polish,	Punjabi,	and	Urdu.	Funding	was	available	to	provide	interpreters	if	
required	and	we	were	able	to	translate	the	workbook	into	different	languages	if	required	by	
participants.	Potential	participants	who	expressed	interest	in	the	study	were	provided	with	a	study	
information	sheet	and	asked	to	provide	their	contact	details	for	the	researcher	to	phone	and	
confirm	if	they	were	interested	in	participating.	Eligible	participants	who	expressed	an	interest	in	
participation	were	screened	over	the	phone	and	were	sent	an	invitation	for	an	assessment	interview	
(which	included	an	explanation	of	the	randomization	process)	at	the	hospital	or	over	the	telephone.	
All	participants	were	required	to	provide	written	consent	to	participate.	
Following	the	assessment	interview	the	researchers	utilised	an	online	and	text-based	randomization	
system	(Sealed	Envelope	Ltd)	to	randomize	participants	at	a	ratio	of	1:1	between	the	intervention	
group	and	usual	care	group.	Participants	were	stratified	by	age	(18-50	years	or	51	and	over)	and	
cancer	type	(breast,	bowel,	gynaecological,	or	urological).	Participants	who	consented	into	the	study	
were	logged	according	to	recruitment	site	using	the	National	Institute	for	Health’s	(NIHR)	Central	
Portfolio	Management	System.	
Intervention		
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The	WorkPlan	package	 is	a	4-week	guided	workbook	 intervention	consisting	of	structured	sections	
and	 activities	 to	 provide	 guidance	 and	 support	 to	 patients.	 The	 workbook	 is	 broken	 down	 into	
chapters.	 Chapter	 one	 focused	 on	 thinking	 about	 illness	 and	 treatment	 (based	 around	 the	 illness	
perceptions	 component	 of	 the	 Self-Regulation	 Model)	 and	 includes	 causes	 of	 cancer,	 symptoms,	
beliefs	 about	 efficacy	 of	 treatment	 and	 consequences	 of	 living	 as	 a	 survivor	 of	 cancer.	 It	 then	
explores	 the	 participant’s	 beliefs	 about	 the	 impact	 of	 cancer	 and	 treatment	 on	 their	 ability	 to	
function	 in	 the	 workplace,	 including	 suggestions	 for	 management.	 The	 chapter	 concludes	 by	
examining	participants’	emotional	reactions	to	treatment	and	support/strategies	to	manage	these.	
Chapter	 two	 is	 focused	 on	 setting	 and	 achieving	 goals	 (based	 on	 Goal	 Theory)	 including	 the	 goal	
setting	process,	 identifying	and	overcoming	barriers	and	utilising	 support.	Chapter	 three	works	on	
building	 confidence,	 including	 ways	 to	 boost	 confidence.	 This	 chapter	 concludes	 by	 examining	
fatigue	 and	ways	 to	 to	 identify	 and	manage	 fatigue	 triggers.	 Chapter	 4	 focuses	 on	 developing	 an	
action	 plan	 for	 returning	 to	 work	 and	 outlines	 how	 to	 initiate	 discussions	 and	 deal	 with	 difficult	
questions	within	the	workplace.		
Participants	were	encouraged	to	work	through	chapters	in	turn	during	each	week	of	the	intervention	
period,	 allocating	 around	 120	 minutes	 per	 week.	 However,	 this	 was	 not	 strictly	 monitored	 and	
participants	had	the	opportunity	 to	work	 through	the	 intervention	at	a	pace	that	suited	them	and	
their	 timeframe	 for	 returning	 to	work.	 Participants	 incorporated	 all	 elements	 from	 the	workbook	
into	 a	 personal	 return	 to	work	plan,	which	 they	were	 encouraged	 to	develop	 in	 the	 final	week.	A	
resources	 section	 signposted	 participants	 toward	 relevant	 avenues	 of	 further	 support.	 Multiple	
copies	of	the	return	to	work	planning	page	were	available	to	encourage	changes	to	be	made	when	
necessary,	 and	 these	 plans	 were	 used	 as	 a	 tool	 when	 meeting	 with	 employers	 to	 aid	 discussion	
around	returning	to	work.	Service	users	in	the	original	pilot	work	(of	the	materials	and	study	design)	
were	concerned	about	raising	work-related	issues	too	early	with	their	employer	and	stated	that	they	
would	 prefer	 to	 engage	 with	 their	 workplace	 after	 completing	 the	 intervention,	 when	 they	 felt	
better	 able	 to	 represent	 their	 view	 and	 had	 formed	 a	 return	 to	 work	 plan.	 Therefore,	 the	
intervention	does	not	have	a	specific	employer	component	but	rather	the	workbook	promotes	skills	
to	enable	communication	with	employers.	
Control	group		
Participants	received	usual	care,	which	focused	on	clinical	care	and	optimal	symptom	management.	
In	order	to	prevent	participants	from	undertaking	activities	in	the	workbook	the	information	sheets	
and	pre-randomization	discussion	did	not	include	the	content	or	focus	of	the	intervention	and	
participants	were	not	offered	the	workbook	until	after	their	12-month	follow-up.	
 8 
Participants	in	both	groups	were	able	to	access	other	information	and	support	relating	to	work	and	
were	therefore	asked	to	record	any	resources	or	information	they	utilised	during	the	trial.		
Study	outcomes	
Primary	outcome	
The	primary	outcomes	were	time	to	return	to	work	and	return	to	work	rates	at	6	and	12	month	
follow-ups.	Any	changes	in	working	status	e.g.	contracted	hours	and	duties	were	documented	along	
with	specific	reasons	for	non-return	to	work	(e.g.,	unavailability	of	job,	ongoing	medical	concerns)	to	
determine	whether	to	incorporate	specific	reasons	for	non-return	as	measures	in	a	full	trial.		
Secondary	outcomes	
Secondary	outcome	measures	included	mood,	satisfaction	with	return	to	work,	and	satisfaction	with	
the	return	to	work	process.		
Data	was	collected	at	4	time	points:	baseline	(T0),	4	weeks	post-intervention	(intervention	group)	or	
4	weeks	post-randomisation	(usual	care	group)	(T1),	and	6-	month	post	randomisation	(T2)	and	12-
month	post-randomisation	(T3)	follow-ups.	At	each	time	point	participants	were	mailed	a	
questionnaire	pack	(with	a	prepaid	self-addressed	envelope)	that	comprised:	(1)	Illness	Perceptions	
Questionnaire-Revised	24;	(2)	Brief	Illness	Perception	at	Work	Scale	25;	(3)	Hospital	Anxiety	and	
Depression	Scale	26;	(4)	Work	Ability	Index	27;	(5)	Satisfaction	with	return	to	work	if	returned	to	work	
(single	item);	(6)	Satisfaction	with	Work	Scale	28	(if	returned	to	work);	(7)EQ-5D-5L	(Quality	of	Life)	29;	
(8)	Visual	Analogue	Scale	measure	of	Quality	of	Life	(single	item)	30.		
Work	status	and	healthcare	utilization	
Participants	provided	details	of	their	use	of	services	and	employment	activity	via	text	message	(using	
JANET;	http://www.pageone.co.uk/services/janet-txt).	A	maximum	of	four	text	messages	were	sent	
to	participants	at	the	end	of	each	month	to	gather	information	on	their	work	status	(i.e.	full-time,	
part-time,	phased	return,	sick	leave,	not	working),	number	of	days	worked	that	month	and	
healthcare	utilization	(number	of	general	practitioner	appointments	that	month).	Monthly	intervals	
were	chosen	as	memory	of	general	practitioner	appointments	is	around	4	weeks,	so	we	could	not	
rely	on	accurate	recall	of	healthcare	utilization	at	6-month	questionnaire	follow-ups	31,	32.	
Adverse	events	
A	record	sheet	was	produced	for	the	recording	of	adverse	events	and	provided	as	part	of	the	study	
file	to	all	participating	sites.	If	participants	reported	any	negative	events,	including	low	mood	or	
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anxiety,	as	a	result	of	taking	part	in	the	study	or	undertaking	the	intervention,	or	if	participants	
withdrew	from	the	study	due	to	an	adverse	event	then	this	were	recorded	on	the	record	sheet.		
Qualitative	interviews	
The	aim	of	the	post-intervention	and	12-month	follow-up	interviews	was	to	better	understand	the	
effects	of	the	intervention	and	to	explore	how	the	intervention	was	experienced	by	participants.	
Participants	were	approached	sequentially	until	the	recruitment	target	was	reached.	Interviews	
were	conducted	over	the	telephone	or	face	to	face,	depending	on	the	participant's	preference.	The	
post-randomization	interview	focused	on	(1)	beliefs	about	work	and	cancer	(2)	experience	of	
employment	and	work	values;	and	(3)	ways	in	which	returning	to	work	could	be	supported	and	(4)	
expectations	of	the	WorkPlan	intervention.	Twelve-month	interviews	explored	(1)	beliefs	about	
cancer	and	work	and	how	these	were	challenged	over	the	preceding	year,	(2)	general	perceptions	of	
the	trial,	and	(3)	the	personal	return	to	work	process	of	each	individual.	
Data	analysis	
Descriptive	statistics	for	all	between	group	outcome	measures	are	presented,	including	means	(SD),	
and	frequencies.	The	purpose	of	this	feasibility	study	was	not	hypothesis	testing	and	the	sample	size	
was	underpowered	to	undertake	the	full	analysis	that	would	be	used	in	a	full	trial	(analysis	of	
covariance	adjusting	for	baseline	values).		
Economic	analysis		
Although	an	economic	evaluation	was	not	suitable	in	the	context	of	a	feasibility	trial,	we	did	aim	to	
determine	whether	data	would	be	obtainable	to	enable	a	full	cost-effectiveness	analysis	in	a	
definitive	trial.		
Qualitative	data	
Interviews	were	audio	recorded,	transcribed	verbatim,	and	analysed	using	the	framework	method	
[46]	to	identify	emergent	themes.	The	consolidated	criteria	for	reporting	qualitative	research	
(COREQ)	were	used	to	guide	the	presentation	of	the	qualitative	analyses.	Findings	from	the	
quantitative	and	qualitative	analyses	are	presented	concurrently	although	fuller	details	of	the	
methodology	for	the	interviews	and	of	the	qualitative	findings	have	been	reported	elsewhere	33.	
	
Patient	and	public	involvement	
The	WorkPlan	intervention	was	developed	following	a	prospective	study,	which	followed	cancer	
patients	for	one	year	following	the	end	of	treatment	to	identify	factors	that	influenced	the	likelihood	
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of	not	returning	to	work.	The	WorkPlan	intervention	was	then	refined	with	input	from	15	cancer	
survivors	who	provided	feedback	on	the	content	and	wording	of	the	workbook	and	format	of	
delivery	(workbook	or	face	to	face	sessions).	One	steering	group	member	and	author	(PR)	was	a	
patient	representative	and	provided	input	on	recruitment,	study	design	and	materials.	Study	
participants	were	asked	if	they	would	like	a	lay	summary	of	the	study	findings	at	the	end	of	the	study	
and	this	was	sent	to	all	who	indicated	that	they	would.		
	
Results	
Eligibility	and	recruitment	
During	the	recruitment	period	324	patients	were	identified	and	assessed	for	eligibility	and	170	
participants	were	ineligible	(reasons	included	not	working	at	time	of	diagnosis,	older	than	70	years	
or	already	returned	to	work).	A	further	154	patients	were	considered	eligible	(Figure	1).	Eighty-six	of	
these	participants	declined	to	participate	resulting	in	68	participants	(44%)	being	consented	and	
randomised	into	the	study.		Although	68	participants	consented	to	take	part	in	the	study	only	58	
returned	fully	completed	T0	(baseline)	questionnaires.	There	was	no	difference	between	those	who	
returned	the	questionnaires	and	those	who	did	not	on	any	of	the	demographic	or	clinical	measures,	
site	of	recruitment,	size	of	employer,	or	randomized	group.	In	the	interviews	participants	reported	
that	the	randomization	process	was	acceptable.		
Furthermore,	23	participants	in	the	intervention	group	were	interviewed	at	the	post-intervention	
(T1)	time-point,	which	exceeded	our	target	of	20.	At	the	12-month	(T3)	follow-up	22	participants	
from	the	intervention	group	and	20	from	the	control	group	participated	in	an	interview,	which	
exceeded	our	target	of	40	participants	in	total.		
Sample	characteristics	
We	were	unable	to	collect	demographic	information	of	participants	who	chose	not	to	consent	into	
the	study.	The	majority	of	participants	self-identified	as	being	White	(88%);	followed	by	
African/Afro-Caribbean	(7%)	and	Asian	(5%)	(Table	1).	There	was	significantly	more	woman	(79%)	
than	men	(21%)	recruited	into	the	study.	This	reflected	the	large	percentage	of	the	participants	who	
had	been	diagnosed	with	breast	cancer	(50%)	and	gynaecological	cancers	(15%)	compared	to	
prostate	(16%)	and	colorectal	(19%).	The	majority	of	participants	were	married	or	living	with	a	
partner	(71%)	and	half	were	educated	to	degree	level	of	above	(50%).	Comorbidities	(defined	as	any	
concurrent	diagnosis	of	a	physical	or	psychological	disorder	for	which	participants	were	currently	
receiving	treatment)	were	more	common	among	the	usual	care	(50%	reporting	one	or	more	
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comorbidities)	than	the	intervention	group	(29%)	and	this	could	be	explored	in	a	future	trial	as	a	
possible	mediator	of	returning	to	work.	
	
Data	collection	
Attrition	
Attrition	rates	(determined	by	non	return	of	the	questionnaire	at	that	time-point)	from	point	of	
randomisation	to	one	month	(T1),	six	months	(T2)	and	12	months	(T3)	follow-up	were	24.5%	(29%	in	
intervention	and	20%	in	control	group),	28%	(29%	in	intervention	and	27%	in	control	group)	and	31%	
respectively	(32%	in	intervention	and	30%	in	control	group).	This	was	slightly	higher	than	the	
conservative	25%	estimate	we	had	forecast	at	12	months.	Attrition	was	higher	when	participants	
were	recruited	into	the	trial	by	research	nurses	(37%	at	T3)	rather	than	the	study	research	assistants	
(19%	at	T3),	potentially	indicating	that	participants	are	more	likely	to	remain	in	a	study	when	they	
had	developed	a	relationship	(through	the	information	and	consent	process)	with	a	researcher	on	
the	project.		
	
Acceptability	of	the	outcome	measures	and	data	collection	methods	
For	the	most	part,	the	outcome	measures	were	acceptable	and	no	participants	raised	study	burden	
as	a	concern	during	the	interviews.	Participants	who	returned	the	questionnaires	at	each	time-point	
mostly	returned	fully	completed	questionnaires	and	did	not	systematically	leave	questions	
unanswered.	We	trialled	using	a	text-based	data	collection	system	for	collecting	monthly	work	data	
and	GP	visits.	This	was	acceptable	to	the	majority	of	participants;	only	two	participants	did	not	have	
access	to	a	mobile	phone	and	so	we	used	monthly	emails	to	collect	this	data	with	these	participants.	
	
Adverse	events	
No	adverse	events	were	reported	during	the	feasibility	trial.		
	
Participants	views	of	the	intervention	
From	the	interviews,	it	was	apparent	that	overall	participants	enjoyed	taking	part	in	the	intervention	
and	that	it	provided	a	focus	and	clarity	regarding	the	process	of	returning	to	work	and	options	that	
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they	might	consider.	The	workbook	was	described	as	a	useful	tool	that	facilitated	the	planning	
process	for	returning	to	work	and	that	the	exercises	within	the	workbook	“broke	it	[the	process]	
down	into	small	bits”.	It	allowed	participants	to	imagine	the	potential	problems	around	roles,	tasks	
and	events	that	could	arise	and	plan	how	to	deal	with	these.	Furthermore,	by	considering	
interactions	in	the	workplace,	such	as	coping	with	co-workers’	reactions,	they	were	able	to	engage	in	
mental	role	play	to	rehearse	how	to	respond,	gaining	confidence	in	managing	a	successful	return	to	
work.	
	
The	workbook	format	of	the	intervention	was	well	received	by	participants	and	preferred	by	the	
majority	of	participants	to	the	idea	of	using	an	online	or	app	version.	The	booklet	was	seen	as	
convenient	(easy	to	access	compared	to	an	online	version),	simple	to	transport	and	could	easily	be	
shared	with	others.	
I	think	the	benefit	of	doing	the	booklet	with	a	pen	in	your	hand	is	that	you	actually	feel	more	
engaged	with	it.	You’re	writing	it	and	you’re	physically	owning	your	words.	Whereas	on	the	
computer	I	think	it	would	be	a	lot	more	impersonal	(P24,	aged	54)	
I’ve	been	able	to	go	to	bed	and	I’ve	been	able	to	read	it.	With	my	phone	it’s	small,	do	you	
know	what	I	mean?	Things	could	be	missed.	If	it’s	a	book	where	you	come	back	to	it	now	and	
again.	It’s	there	at	the	side	of	my	bed	and	kind	of	prompts	you	to	do	it.	(P10,	aged	44)	
However,	a	minority	of	interviewees	did	suggest	that	it	would	be	more	secure	(requiring	a	password)	
and	environmentally	friendly	to	have	an	online	version.	
	
Although	the	intervention	was	perceived	as	useful	some	interviewees	did	highlight	areas	that	could	
either	have	been	more	detailed	in	the	booklet	or	that	had	not	been	included.	The	main	area	where	
participants	required	greater	detail	was	about	managing	finances	during	sick	leave	periods	and	
about	financial	support	that	could	be	available	to	them.	This	is	an	area	of	the	current	intervention	
that	would	need	to	be	adapted	before	moving	to	a	full	trial.	Furthermore,	during	the	interviews	one	
participant	commented	on	the	wording	of	the	booklet,	which	referred	to	patients	having	completed	
treatment,	whereas	the	patient	was	still	going	through	treatment	and	this	made	it	difficult	for	them	
to	engage	suggesting	that	the	booklet	might	need	rewording.	
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I	was	still	trying	to	go	through	treatment	and	it	was	talking	about	the	process	when	it	had	all	
finished.	I	was	still	going	through	treatment,	so	I	remember	being	quite	annoyed	about	that	
(P15).	
	
Outcomes	measures	
The	primary	outcomes	were	time	to	return	to	work	and	return	to	work	rates	at	6	and	12	month	
follow-ups.	There	were	no	significant	differences	between	the	usual	care	and	intervention	group	in	
terms	of	the	number	of	days	from	leaving	work	to	returning	to	work	(usual	care	mean	308	days	(SD	
74)	compared	to	intervention	mean	of	333	days	(SD	153)).	The	greater	number	of	days	observed	for	
the	intervention	group	was	likely	influenced	by	the	fact	that	within	the	intervention	group	(mean	
190	days,	SD	145)	there	were	a	greater	number	of	days	(non-significant)	between	leaving	and	
consenting	into	the	study	(so	this	group	had	already	been	out	of	work	for	a	longer	period	of	time)	
compared	to	the	usual	care	group	(mean	158	days,	SD	100).		Although	the	intervention	group	
reported	a	greater	number	of	days	worked	per	month	at	6	and	12-month	follow-up	(Table	2),	these	
did	not	reach	significance,	possibly	due	to	lack	of	power.	In	addition,	at	6-month	follow-up	30%	of	
participants	in	the	usual	care	group	had	returned	to	full	or	part-time	work	compared	to	43%	of	the	
intervention	group.	At	12	months,	the	percentages	were	47%	(usual	care)	and	68%	(intervention).	
Regarding	secondary	outcome	measures,	the	intervention	group	reported	less	anxiety	and	
depression-related	symptoms	although	these	did	not	reach	significance	and	would	need	to	be	
examined	as	part	of	a	fully	powered	RCT.	There	was	potentially	a	floor	effect	with	the	EQ-5D	(health	
status)	with	few	symptoms	reported	at	each	time-point,	resulting	in	low	scores	across	participants	
with	limited	dispersion	of	the	scores.		
	
	
Discussion	
This	study	aimed	to	assess	the	feasibility	and	acceptability	of	an	RCT	of	a	workbook	intervention	to	
support	cancer	patients	in	returning	to	work.	Our	results	indicate	that	the	format	of	the	workbook	
was	well	received	and	that	the	exercises	within	the	workbook	were	engaging	and	useful	in	the	
return	to	work	process.	However,	it	should	be	noted	that	this	may	be	a	consequence	of	
acquiescence	bias	or	lack	of	awareness	of	the	utility	of	an	alternative	to	format	used	within	the	trial.	
An	unexpected	outcome	was	the	degree	to	which	participants	valued	the	process	of	writing	within	a	
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physical	workbook.	The	workbook	aided	them	in	organising	their	thoughts,	enabling	them	to	plan	for	
the	future.	Expressive	writing,	or	the	formation	of	a	written	narrative	exploring	the	emotional	
aspects	of	a	personal	experience,	allows	an	individual	to	organise	own	thoughts	and	emotions	into	a	
coherent	narrative,	or	summary,	that	can	facilitate	more	effective	coping	34,	35.	Using	the	WorkPlan	
workbook	was	not	intended	to	act	as	an	expressive	writing	task,	however,	it	enabled	participants	to	
explore	thoughts	and	emotions	related	to	their	cancer	and	to	work	and	the	work	environment	
including	organisational	(support,	shift	patterns)	aspects	of	their	work;	a	process	which	participants	
identified	as	both	supportive	and	enjoyable.	There	is	a	clear	need	for	an	intervention,	such	as	
WorkPlan,	to	support	patients	in	planning	their	return	to	work	and	to	support	them	in	thinking	
about	how	they	could	overcome	potential	issues	associated	with	work	tasks,	their	role	
(responsibilities)		as	well	accommodating	ongoing	medical	care	and	treatment	(i.e.	fitting	work	
requirements	around	medical	consultations	and	treatment).	
	
The	recruitment	rate	was	44%,	which	was	acceptable	and	in-line	with	other	studies.	However,	there	
were	fewer	men	recruited	(21%)	than	we	had	expected,	which	was	due	in	part	to	the	cancer	types	
that	we	recruited	into	the	study	with	two-thirds	of	participants	having	been	diagnosed	with	breast	
or	gynaecological	cancers.	In	a	future	trial,	we	would	widen	the	range	of	cancer	types	that	would	be	
eligible	for	inclusion	and	stratify	by	gender	as	well	as	age.	The	majority	of	participants	also	identified	
as	being	White	(88%),	however,	within	the	Birmingham	area	(where	the	majority	of	recruitment	took	
place)	around	81%	of	the	population	were	classified	as	White36	and	therefore	the	findings	may	not	
be	representative	of	cancer	patients	returning	to	work	after	treatment.	A	future	trial	will	need	to	
make	male	and	minority	recruitment	a	priority	and	recruitment	materials	may	need	amending	to	be	
more	relevant	to	these	groups	37.	In	addition,	although	we	translated	recruitment	materials	into	five	
languages	to	support	recruitment	of	non-English	speakers	into	the	study	we	were	unsuccessful	in	
recruiting	any	non-English	speakers.	However,	the	main	barrier	to	recruiting	non-English	speakers	
was	not	necessarily	a	language	barrier	but	rather	that	that	the	majority	of	those	approached	were	
not	working	at	the	time	of	diagnosis.	Finally,	half	of	study	participants	were	educated	to	degree	level	
and,	although	this	is	in-line	with	numbers	of	school	leavers	entering	tertiary	education	in	the	UK	
today,	it	is	higher	than	would	have	been	observed	among	the	age	groups	included	in	this	study	and	
therefore	further	work	is	needed	to	understand	the	reason	for	low	uptake	into	the	study	of	people	
leaving	education	at	an	earlier	age. 	
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Overall,	the	study	design,	using	a	nested	qualitative	evaluation,	was	found	to	be	feasible. A	key	
strength	of	this	study	was	the	mixed-methods	approach,	which	allowed	for	triangulation	of	
experiences	of	the	participants.	Qualitative	methods	provided	depth	of	understanding	and	the	
findings,	particularly	exploration	of	trial	acceptability,	suggested	that	participants	were	generally	
satisfied	with	the	process	and	found	the	experience	acceptable	and	informative.	However,	patients	
may	have	been	inclined	to	produce	socially	desirable	responses,	although	with	attrition	rates	within	
tolerable	limits	there	is	additional	support	for	the	acceptability	of	the	study	process.	Finally,	the	
insights	emerging	from	this	study	relied	on	in-depth	qualitative	investigation,	however,	it	should	be	
noted	that	the	findings	are	limited	to	predominately	female,	Caucasian	participants.		
	
This	was	a	feasibility	study	and	so	efficacy	testing	was	not	an	aim	of	the	study	and	the	small	sample	
size	was	likely	insufficient	to	detect	subtle	differences	between	groups.	The	primary	outcome	
measures	were	return	to	work	rates	at	6	and	12	month	follow-ups	and	in	a	future	trial	we	would	also	
use	the	text	based	data	collection	system	to	collect	information	about	actual	return	to	work	date.	
Determining	the	economic	cost	of	the	intervention	is	important	given	that	although	there	is	strong	
evidence	of	return	to	work	interventions	providing	cost	savings	from	a	societal	perspective	there	is	a	
need	to	ensure	that	actual	intervention	costs	would	be	manageable	once	the	intervention	was	
implemented	38.		The	outcomes	for	use	in	an	economic	analysis	in	a	full	trial	were	found	to	be	
feasible	and	acceptable.	In	particular,	the	tool	for	collecting	data	on	work	behaviour	and	GP	
attendance	was	successful,	and	the	burden	on	participants	did	not	appear	to	be	excessive.	In	a	
future	trial	we	would	also	collect	information	about	additional	services	that	were	utilised	(e.g.	out	of	
hours	primary	care	services,	minor	injury	units	and	counselling	services),	the	number	of	hours/days	
of	work	that	are	missed	(in	this	trial	we	collected	data	on	the	number	of	days	worked),	as	these	
could	contribute	to	societal	costs.	Furthermore,	the	aim	of	the	study	was	to	explore	the	feasibility	of	
undertaking	an	RCT	of	the	WorkPlan	intervention	and	this,	along	with	the	small	sample	size,	meant	
that	we	did	not	examine	the	role	of	socioeconomic	factors	or	type	of	employment	as	a	mediator	of	
returning	to	work	in	each	of	the	groups.	However,	this	data	(including	job	title	and	postcode)	was	
collected	and	could	be	utilised	in	a	future	trial.		
	
Following	on	from	the	findings	of	the	feasibility	study	there	are	a	number	of	adaptations	proposed	
for	a	future	study.		A	limitation	of	the	current	study	is	that	the	views	of	Black	and	ethnic	minority	
groups	are	under-represented.		The	recruitment	materials	and	how	patients	are	identified	and	
approached	will	need	refining	to	increase	the	number	of	men	and	Black	and	ethnic	minority	
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participants.	Attrition	was	higher	among	participants	recruited	from	sites	with	research	nurses	
rather	than	sites	where	the	study	research	assistants	recruited,	which	may	be	partly	due	to	rapport	
and	knowledge	of	the	project,	both	of	which	have	been	reported	to	impact	recruitment39.	To	
improve	retention,	particularly	from	sites	where	the	participants	are	not	recruited	by	the	study	
research	assistants,	there	needs	to	be	greater	effort	to	build	rapport	with	participants	and	
encourage	retention	in	the	trial.	In	addition,	although	we	used	incentives	to	encourage	participation	
(including	a	£20	voucher	for	completing	the	assessment	interview)	it	may	be	that	greater	
consideration	needs	to	be	given	to	compensating	participants	for	their	time	throughout	the	12-
month	study.	A	further	limitation	is	that	the	study	did	not	include	the	views	and	experiences	of	
employers,	who	may	hold	negative	beliefs	about	the	ability	of	cancer	survivors	to	return	to	work25	
and	therefore	impact	on	the	process	of	returning	to	work.		Finally,	although	we	examined	
engagement	and	acceptability	of	the	intervention	(through	the	interviews)	we	did	not	test	the	
fidelity	of	the	intervention	as	part	of	this	feasibility	trial.	Therefore,	in	a	full	RCT	we	would	
systematically	assess	intervention	fidelity	and,	where	possible,	incorporate	fidelity	data	in	the	
analysis	of	outcomes40.	
	
Conclusion	
This	study	investigated	the	feasibility	of	undertaking	an	RCT	of	a	workbook	based	intervention	to	
support	cancer	patients	in	returning	to	the	workplace.	The	initial	results	are	encouraging	and	
suggest	that	the	intervention	was	both	well	received	and	conveyed	benefit	to	participants	in	
supporting	return	to	work	after	cancer	treatment.	The	findings	suggest	that,	with	minor	
modifications,	an	effectiveness	RCT	is	warranted.		
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Figure	legends	
Figure	1:	Flow	of	participants	through	the	study	(showing	cumulative	attrition	at	each	time-point	
from	point	of	randomization)	
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Table	1.	Participant	Demographics	
	 Usual	care	
(n=30)	
Intervention	
group	(n=38)	
All	(n=68)	
Age,	mean	(range)	
	
51.2	(35-63)	 50.4	(25-65)	 50.8	(25-65)	
Gender	n(%)	
  Female	
  Male	
	
26(87)	
4(13)	
	
28(74)	
10(26)	
	
54(79)	
14(21)	
Marital	Status	n(%)	
  Married	or	Living	with	Partner	
  Divorced	or	Separated	
  Single	and	Never	Married	
  	
	
20(67)	
6(20)	
4(13)	
	
28(74)	
6(16)	
4(10)	
	
48(71)	
12(18)	
8(11)	
Dependent	children	living	at	home	n(%)	
	
13(43)	 13(34)	 26(38)	
Ethnicity	n(%)	
White	
Asian	
African/Afro-Caribbean	
	
	
25(83)	
2(8.5)	
2(8.5)	
	
35(90)	
1(3)	
3(7)	
	
60(88)	
3(5)	
5(7)	
Highest	education	level	n(%)	
Did	not	complete	secondary	education	
Secondary	education	(to	16	years)	
Further	education	(to	18	years)	
Higher	education	(degree	or	higher)	
	
	
0(0)	
14(47)	
3(10)	
13(43)	
	
1(3)	
9(24)	
7(18)	
21(55)	
	
1(1)	
23(34)	
10(15)	
34(50)	
Cancer	Diagnosis	n(%)	
  Breast	
  Urological	
  Bowel	
  Gynaecological	
  	
	
16(53)	
2(7)	
7(23)	
5(17)	
	
18(46)	
9(24)	
6(16)	
5(14)	
	
34(50)	
11(16)	
13(19)	
10(15)	
Comorbidities	n(%)	
1	
2	
3	or	more	
	
	
8(27)	
1(3)	
6(20)	
	
8(21)	
0(0)	
5(13)	
	
16(24)	
1(1)	
11(16)	
Flexible	working	allowed	n(%)	
	
7(23)	 18(48)	 25(37)	
Number	of	months	entitled	to	full	sick	pay;	
mean(SD)	
	
3.9	(2.7)	 4.8	(3.2)	 4.4	(2.9)	
Work	status	at	6	month	follow-up	n(%)	
  Working	full/part	time*	
  	
	
9(30)	
	
16(43)	
	
25(37)	
Work	status	at	12	month	follow-up	n(%)	
  Working	full/part	time*	
	
14(47)	
	
26(68)	
	
40(59)	
*Including	phased	return	to	work	
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Table	2	Outcome	measures	by	assessment	time	point	and	group	
	
	 Study	group	 T0	baseline	
mean	(SD)	
T1	post	
intervention	
mean	(SD)	
T2	6-month	
follow-up	
mean	(SD)	
T3	
12month	
follow-up	
mean	(SD)	
Emotion	(IPQ-R)	 Usual	care	 2.7	(0.6)	 2.6	(0.7)	 2.4	(0.5)	 2.6	(0.6)	
Intervention	 2.9	(0.6)	 2.6	(0.7)	 2.6	(0.5)	 2.7	(0.7)	
Timeline	(IPQ-R)	 Usual	care	 3.3	(0.1)	 3.3	(0.6)	 3.1	(0.5)	 3.0	(0.5)	
Intervention	 2.9	(0.1)	 3.1	(0.7)	 3.1	(0.6)	 3.0	(0.8)	
Illness	coherence	(IPQ-R)		 Usual	care	 3.3	(0.5)	 3.3	(0.6)	 3.4	(0.6)	 3.5	(0.6)	
Intervention	 3.1	(0.7)	 3.1	(0.7)	 3.1	(0.7)	 3.2	(0.8)	
Illness	consequences	(IPQ-R)	 Usual	care	 3.9	(0.7)	 3.9	(0.5)	 3.9	(0.3)	 3.9	(0.3)	
Intervention	 3.9	(0.7)	 4.0	(0.4)	 3.8	(0.4)	 3.9	(0.4)	
Personal	control	(IPQ-R)	 Usual	care	 3.4	(0.8)	 3.4	(0.4)	 3.4	(0.4)	 3.2	(0.4)	
Intervention	 3.3	(0.8)	 3.3	(0.6)	 3.3	(0.4)	 3.2	(0.7)	
Treatment	control	(IPQ-R)	 Usual	care	 3.5	(0.4)	 3.5	(0.4)	 3.5	(0.4)	 3.4	(0.4)	
Intervention	 3.5	(0.4)	 3.4	(0.4)	 3.5	(0.3)	 3.5	(0.4)	
Brief	illness	perception	at	
work	scale		
Usual	care	 3.6	(0.5)	 3.7	(0.9)	 3.6	(0.9)	 3.4	(0.5)	
Intervention	 4.0	(0.9)	 3.6	(0.7)	 3.4	(1.1)	 3.6	(0.9)	
EQ-5D-5L	(health	status)		 Usual	care	 2.1	(0.1)	 1.8	(0.6)	 1.7	(0.5)	 1.6	(0.5)	
Intervention	 1.7	(0.8)	 1.6	(0.5)	 1.6	(0.4)	 1.5	(0.4)	
Visual	analogue	scale	
measure	of	quality	of	life		
Usual	care	 56.2	(18.7)	 59.3	(20.7)	 71.6	(17.9)	 75.0	(19.5)	
Intervention	 61.6	(19.3)	 68.0	(22.6)	 73.7	(14.7)	 77.8	(17.1)	
Anxiety	(HADS)		 Usual	care	 8.3	(4.3)	 7.9	(4.4)	 7.2	(4.5)	 6.7	(3.4)	
Intervention	 7.2	(4.3)	 7.3	(4.5)	 6.3	(3.5)	 6.1	(4.2)	
Depression	(HADS)	 Usual	care	 5.8	(3.0)	 5.0	(3.8)	 4.9	(3.6)	 4.5	(4.3)	
Intervention	 6.1	(4.1)	 5.6	(4.2)	 4.7	(3.5)	 3.9	(3.1)	
Work	ability	index	(overall)	 Usual	care	 4.3	(0.7)	 4.4	(3.1)	 6.7	(2.8)	 7.6	(2.6)	
Intervention	 2.7	(0.5)	 5.4	(3.7)	 6.6	(3.4)	 7.8	(3.0)	
Work	ability	index	(physical	
demands	of	role)	
Usual	care	 2.5	(0.3)	 2.8	(1.1)	 3.2	(1.0)	 3.8	(1.0)	
Intervention	 2.3	(0.5)	 3.2	(1.2)	 3.3	(1.3)	 3.9	(1.2)	
Work	ability	index	(cognitive	
demands	of	role)	
Usual	care	 2.7	(0.2)	 2.9	(1.2)	 3.1	(1.3)	 3.7	(1.2)	
Intervention	 2.5	(0.2)	 3.0	(1.3)	 3.2	(1.2)	 3.9	(1.2)	
Satisfaction	with	work	scale		 Usual	care	 3.7	(0.7)	 3.5	(0.6)	 3.5	(0.7)	 3.4	(0.6)	
Intervention	 3.4	(0.9)	 3.3	(1.0)	 3.3	(1.1)	 3.3	(1.0)	
Number	of	days	worked	
that	month	
Usual	care	 -	 3.5	(7.7)	 5.7	(8.7)	 11.5	(10.1)	
Intervention	 -	 3.4	(6.5)	 8.9	(9.2)	 12.4	(7.9)	
	
	
	
 
 
	
 
	
